IART

Integra LifeSciences Holdings Corporation
$16.92
+0.03 (+0.18%)
Mkt Cap 1.32B
Volume 581,068
52W Range 8.7-20.49
Sector Healthcare
Beta 1.21
EPS (TTM) -0.09 USD
P/E Ratio -1.85
Revenue (TTM) 1.65B USD
Rev Growth (5Y) +3.6%
EPS Growth (5Y) N/A
AlphaVal · Fair Value
What we estimate one share is worth
$14.64
Overvalued moderate signal
15.6% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Stable Earnings Power
30.0 / 100 pillar composite (overridden)
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 1.64B 1.61B 1.54B 1.56B 1.54B 1.37B 1.52B 1.47B 1.19B 992.08M 882.73M 928.30M
Net Income (516.47M) (6.94M) 67.74M 180.55M 169.07M 133.89M 50.20M 60.80M 64.74M 74.56M (3.52M) 34.00M
EPS -6.73 -0.09 0.87 2.18 2.00 1.58 0.59 0.73 0.83 1.00 -0.05 0.52
Free Cash Flow (45.25M) 24.96M 73.09M 217.38M 264.35M 139.94M 96.90M 121.94M 71.04M 69.08M 61.07M 37.07M
FCF / Share -0.59 0.32 0.94 2.62 3.12 1.65 1.13 1.47 0.91 0.92 0.83 0.57
Operating CF 50.38M 129.38M 139.96M 264.47M 312.43M 203.83M 231.43M 199.68M 114.54M 116.41M 94.48M 79.46M
Total Assets 3.60B 4.04B 3.78B 3.89B 3.78B 3.62B 3.30B 3.11B 3.21B 1.81B 1.77B 1.58B
Total Debt 2.03B 1.98B 1.68B 1.63B 1.67B 1.66B 1.46B 1.35B 1.84B 665.00M 714.97M 630.00M
Cash & Equiv 235.05M 246.38M 276.40M 456.66M 513.45M 470.17M 198.91M 138.84M 174.94M 102.06M 48.13M 71.99M
Book Value 1.04B 1.55B 1.59B 1.80B 1.68B 1.51B 1.42B 1.38B 962.31M 839.67M 751.44M 704.32M
Return on Equity -0.49 -0.00 0.04 0.10 0.10 0.09 0.04 0.04 0.07 0.09 -0.00 0.05
IART News
Integra (IART) Down 1.6% Since Last Earnings Report: Can It Rebound?
Aug 28, 2026 08:36 AM · zacks.com
Why Integra LifeSciences (IART) is a Top Value Stock for the Long-Term
Aug 27, 2026 06:40 AM · zacks.com
Can IART's SurgiMend Relaunch Help Drive a Broader 2027 Recovery?
Aug 20, 2026 07:51 AM · zacks.com
Is IART Still Attractive as Its Low Valuation Meets Execution Risks?
Aug 19, 2026 08:36 AM · zacks.com
Here's Why Integra LifeSciences (IART) is a Strong Momentum Stock
Aug 05, 2026 06:51 AM · zacks.com
Integra LifeSciences Holdings Corporation (IART) Q2 2026 Earnings Call Transcript
Jul 29, 2026 03:33 PM · seekingalpha.com
3 Stocks Showing Breakout Potential Ahead of August
Jul 29, 2026 12:01 PM · zacks.com
Integra (IART) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Jul 29, 2026 07:31 AM · zacks.com
Integra LifeSciences Q2 Earnings Call Highlights
Jul 29, 2026 07:07 AM · marketbeat.com
Integra LifeSciences (IART) Q2 Earnings Top Estimates
Jul 29, 2026 04:31 AM · zacks.com